Journal article · 2026 · Open access
Plasma pTau 217/β-amyloid 1–42 ratio for enhanced accuracy and reduced uncertainty in detecting amyloid pathology
Brain, 149(4), 1168–1181 · Published 6 January 2026 · DOI 10.1093/brain/awag001
In brief
“Plasma pTau 217/β-amyloid 1–42 ratio for enhanced accuracy and reduced uncertainty in detecting amyloid pathology” is a 2026 journal article by Natalya Benina and 19 co-authors, published in Brain. OpenAlex counts 18 citations as of 17 November 2026, which puts it in the top 1% of works published in 2026 by citations. It is open access under a CC BY-NC licence: the full text is free to read at Brain.
- Citations
- 18
- Most cited in
- 2026 (18)
- Field-weighted impact
- 50.33
- References
- 47
- Authors
- 20
Abstract
Blood biomarkers have the potential to revolutionize Alzheimer's disease diagnosis, offering advantages over CSF and PET due to their accessibility, scalability and cost-effectiveness. This study evaluated the effectiveness of individual plasma biomarkers, such as phosphorylated Tau (pTau) 217, as well as biomarker combinations, with a focus on the pTau 217/β-Amyloid (Aβ) 1-42 ratio to predict amyloid positivity. To improve clinical utility, a dual threshold approach was applied to maximize predictive values and positive likelihood ratios while minimizing the proportion of indeterminate results. Plasma samples from 208 participants (including seven with subjective cognitive decline, 150 with mild cognitive impairment, 12 with Alzheimer's disease dementia and 39 with other cognitive conditions) from three cohorts (BioFINDER2, BIOCARD and MissionAD) were analysed to measure Aβ1-42, Aβ1-40 and pTau217 levels using the Fujirebio LUMIPULSE® G1200 platform. Amyloid status was determined by FDA-cleared PET imaging and/or CSF biomarker ratios. Logistic regression modelling evaluated biomarkers either individually or in combination to identify those that best distinguished amyloid positivity. Clinically applicable thresholds were established through likelihood ratio analysis and further evaluated based on predictive values. When assessing the ability of individual plasma biomarkers to differentiate between amyloid-positive and amyloid-negative participants, plasma pTau217 (P < 0.001) and plasma Aβ1-42 (P = 0.0056) demonstrated significant discriminative power, whereas Aβ1-40 (P = 0.30) did not. Notably, the integration of these biomarkers into the plasma pTau217/Aβ1-42 ratio demonstrated enhanced classification performance (P < 0.001). Using a two-threshold approach based on positive and negative likelihood ratios (PLR/NLR) targets of 14/20, respectively, the plasma pTau217/Aβ1-42 ratio achieved a positive predictive value (PPV) of 94.44% and negative predictive value (NPV) of 94.28%, in the parametric model, comparable to plasma pTau217 alone (PPV: 94.44%, NPV: 94.28%), but yielded fewer indeterminate results (26.5% versus 38.6%). Using a non-parametric model, the plasma ratio achieved a PPV and NPV of 94.62% and 91.78%, respectively, while plasma pTau217 alone achieved 92.41% and 92.86%; the ratio once again reduced the proportion of indeterminate results (20.2% versus 35.1%). The plasma pTau217/Aβ1-42 ratio demonstrated superior performance in identifying amyloid pathology and reduced the frequency of indeterminate results compared to plasma pTau217 alone. These findings support the evaluation of the clinical utility of the plasma pTau217/Aβ1-42 ratio as a tool for identifying amyloid pathology in patients presenting with cognitive complaints.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Benina, N., Buitrago, L., De Simone, F. I., Radwan, R. R., Miller, M. C., Martin, K., Dickson, D. L., Ho, S. G., Moghekar, A., Albert, M., Mattsson, N., Palmqvist, S., Ossenkoppele, R., Jonsson, M. F., Hansson, O., Stomrud, E., Sachdev, P., Niu, H., Verbel, D., & Hawkins, D. (2026). Plasma pTau 217/β-amyloid 1–42 ratio for enhanced accuracy and reduced uncertainty in detecting amyloid pathology. Brain, 149(4), 1168–1181. https://doi.org/10.1093/brain/awag001
MLA 9
Benina, Natalya, et al. “Plasma pTau 217/β-amyloid 1–42 ratio for enhanced accuracy and reduced uncertainty in detecting amyloid pathology.” Brain, vol. 149, no. 4, 2026, pp. 1168–1181. https://doi.org/10.1093/brain/awag001.
Chicago
Benina, Natalya, Luna Buitrago, Francesca I De Simone, Rachel R. Radwan, M. Craig Miller, Katie Martin, Diana L. Dickson, et al. 2026. “Plasma pTau 217/β-amyloid 1–42 ratio for enhanced accuracy and reduced uncertainty in detecting amyloid pathology.” Brain 149 (4): 1168–1181. https://doi.org/10.1093/brain/awag001.
Harvard
Benina, N. et al. (2026) ‘Plasma pTau 217/β-amyloid 1–42 ratio for enhanced accuracy and reduced uncertainty in detecting amyloid pathology’, Brain, 149(4), pp. 1168–1181. doi:10.1093/brain/awag001.
IEEE
N. Benina et al., “Plasma pTau 217/β-amyloid 1–42 ratio for enhanced accuracy and reduced uncertainty in detecting amyloid pathology,” Brain, vol. 149, no. 4, pp. 1168–1181, 2026, doi: 10.1093/brain/awag001.
BibTeX
@article{benina2026plasma,
title = {{Plasma pTau 217/β-amyloid 1–42 ratio for enhanced accuracy and reduced uncertainty in detecting amyloid pathology}},
author = {Benina, Natalya and Buitrago, Luna and De Simone, Francesca I and Radwan, Rachel R. and Miller, M. Craig and Martin, Katie and Dickson, Diana L. and Ho, Sara G. and Moghekar, Abhay and Albert, Marilyn and Mattsson, Niklas and Palmqvist, Sebastian and Ossenkoppele, Rik and Jonsson, Magnus Förnvik and Hansson, Oskar and Stomrud, Erik and Sachdev, Pallavi and Niu, Hongmei and Verbel, David and Hawkins, DM},
journal = {Brain},
year = {2026},
volume = {149},
number = {4},
pages = {1168--1181},
doi = {10.1093/brain/awag001},
url = {https://doi.org/10.1093/brain/awag001}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- plasma biomarkers
- phosphorylated tau217
- amyloid-beta 42
- Aβ40
- Alzheimer's disease
- likelihood ratios
- positive predictive value
- negative predictive value
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Benina, N., Buitrago, L., De Simone, F. I., Radwan, R. R., Miller, M. C., Martin, K., Dickson, D. L., Ho, S. G., Moghekar, A., Albert, M., Mattsson, N., Palmqvist, S., Ossenkoppele, R., Jonsson, M. F., Hansson, O., Stomrud, E., Sachdev, P., Niu, H., Verbel, D., & Hawkins, D. (2026). Plasma pTau 217/β-amyloid 1–42 ratio for enhanced accuracy and reduced uncertainty in detecting amyloid pathology. Brain, 149(4), 1168–1181. https://doi.org/10.1093/brain/awag001
How many times has this paper been cited?
18 times, according to OpenAlex on 17 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Brain: sign in and open the full text from this page.
Who wrote this paper?
Natalya Benina, Luna Buitrago, Francesca I De Simone, Rachel R. Radwan, M. Craig Miller, Katie Martin, Diana L. Dickson, Sara G. Ho, Abhay Moghekar, Marilyn Albert, Niklas Mattsson, Sebastian Palmqvist and 8 more.
What is the DOI of this paper?
10.1093/brain/awag001, permanently at https://doi.org/10.1093/brain/awag001. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 17 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.